IL-17RC: a partner in IL-17 signaling and beyond
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
The interleukin (IL)-17 cytokine family members IL-17A and IL-17F mediate inflammatory activities via the IL-17 receptor (IL-17R) complex, comprised of the IL-17RA and IL-17RC subunits. Proper regulation of the IL-17 signaling axis results in effective host defense against extracellular pathogens, while aberrant signaling can drive autoimmune pathology. Elucidating the molecular mechanisms underlying IL-17 signal transduction can yield an enhanced understanding of inflammatory immune processes and also create an avenue for therapeutic intervention in the treatment of IL-17-dependent diseases. To date, the fundamental signaling mechanisms used by the IL-17R complex are still incompletely defined. While current structure-function studies have primarily focused on the IL-17RA subunit, recent research indicates that the IL-17RC subunit plays a key role in modulating IL-17 responses. This review will examine what is known regarding IL-17RC function and provide a framework for future work on this subunit and its impact on human health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 is a key mediator of defense against candidiasis.”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [17]
In the citing paper
“IL-17RA-/-, IL-17RC-/-, RORγt-/- and IL-17A-/- mice are all susceptible to systemic C. albicans infection [14–17].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · cited 3×
“As expected given its central role in regulating inflammation, IL-17 mediates many autoimmune diseases and protects against a variety of extracellular pathogens (reviewed in [3]).”
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 1×
“responses by driving the production of innate mediators such as IL-6, CXC chemokines, antimicrobial factors, and acute phase proteins [4, 5].”
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., Modrusan, Z., Ghilardi, N., de Sauvage, F. J., et al. (2008) · Nature Medicine · doi:10.1038/nm1720 · Cited by 1,921 · cited 1×
“Consistent with these data, mIL-17RC−/− fibroblasts do not produce IL-6 or granulocyte-macrophage colony-stimulating factor in response to IL-17A or IL-17F stimulation, lending further support to the necessity of IL-17RC for signaling [47].”
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804 · cited 1×
“IL-6 activation of Stat3 in tumor cells results in increases in anti-apoptotic, proproliferative, and pro-angiogenic genes, as well as suppression of certain proinflammatory genes [53].”
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
Ouyang, W., Kolls, J. K., & Zheng, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.004 · Cited by 1,700 · cited 1×
“Th17 cells play a major role at mucosal surfaces to promote inflammation, providing a beneficial function in an infection setting and deleterious one in an autoimmune context [6, 7].”
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
Self-citationSuppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice
Nakae, S., Nambu, A., Sudo, K., & Iwakura, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6173 · Cited by 1,273
IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00243-6 · Cited by 1,203 · cited 1×
“IL-17E, more commonly called IL-25, shares structural features with other IL-17 family members, though its biologic functions differ considerably [11, 12].”
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., & Iwakura, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00391-6 · Cited by 1,052 · cited 1×
“In an ovalbumin–alum-induced asthma model, IL-17F restricts the pathogenic role of Th2 cells, whereas IL-17A and IL17RA promote Th2 responses in the lung [48, 91, 92].”
Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081463 · Cited by 1,024 · cited 1×
“Additionally, IL-17 clearly plays an integral role in host defense against extracellular pathogens, specifically gram negative bacteria and fungi at mucosal surfaces [9, 94].”
Self-citationIshigame, H., Kakuta, S., Nagai, T., Kadoki, M., Nambu, A., Komiyama, Y., Fujikado, N., Tanahashi, Y., Akitsu, A., Kotaki, H., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.009 · Cited by 1,004 · cited 3×
“Although IL-17A and IL17F have many overlapping effects including immunity to extracellular pathogens and neutrophil recruitment, their respective cytokine knockout models indicate that IL-17A plays a more significant role in driving autoimmunity [40, 48].”
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994 · cited 1×
“Conversely, IL-17RA is highly expressed in the bone marrow, thymus, and spleen, but relatively low levels are detected in colon, small intestine, and lung [26, 40, 42].”
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L., & Miossec, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<963::aid-anr15>3.0.co;2-e · Cited by 954
Interleukin-17 family and IL-17 receptors
Moseley, T. A., Haudenschild, D. R., Rose, L., & Reddi, A. H. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00002-9 · Cited by 918 · cited 2×
“IL-17A and IL-17F (which are ∼55% homologous) are both produced by Th17 cells and are the best-characterized family members to date [13].”
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845 · cited 1×
“Semin Immunopathol (2010) 32:33–42 37 independent manner [65, 66 ].”
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842 · cited 1×
“Furthermore, in the murine B16 melanoma tumor model, IL-17A mediates a protumor function that involves IL-6 induction to activate Stat3 in both tumor cells as well as the tumor microenvironment [52].”
Interleukin-17 promotes angiogenesis and tumor growth
Numasaki, M. (2003) · Blood · doi:10.1182/blood-2002-05-1461 · Cited by 834
Kryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wei, S., Huang, E., Finlayson, E., Simeone, D., Welling, T. H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208249 · Cited by 813
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
Arican, O., Aral, M., Sasmaz, S., & Ciragil, P. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.273 · Cited by 805
A protective function for interleukin 17A in T cell–mediated intestinal inflammation
O'Connor Jr, W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., & Flavell, R. A. (2009) · Nature Immunology · doi:10.1038/ni.1736 · Cited by 756 · cited 8×
“In mice, T cells deficient in IL-17A or IL-17RA mediate a more severe form of colitis, indicating a protective role for IL-17A in an adoptive transfer model of IBD [50].”
InfluentialRegulation of inflammatory responses by IL-17F
Yang, X. O., Chang, S. H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y.-H., Schluns, K. S., Broaddus, R. R., Zhu, Z., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071978 · Cited by 739 · cited 4×
“Although IL-17A and IL17F have many overlapping effects including immunity to extracellular pathogens and neutrophil recruitment, their respective cytokine knockout models indicate that IL-17A plays a more significant role in driving autoimmunity [40, 48].”
InfluentialLubberts, E., Koenders, M. I., Oppers‐Walgreen, B., van den Bersselaar, L., Coenen‐de Roo, C. J. J., Joosten, L. A. B., & van den Berg, W. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20001 · Cited by 709
Th17 Cell Differentiation: The Long and Winding Road
McGeachy, M. J., & Cua, D. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.001 · Cited by 701 · cited 1×
“The generation and function of IL-17-producing cells and the effects of their cognate cytokines have been reviewed extensively elsewhere [2, 3, 8, 9].”
Chan, J. R., Blumenschein, W., Murphy, E., Diveu, C., Wiekowski, M., Abbondanzo, S., Lucian, L., Geissler, R., Brodie, S., Kimball, A. B., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060244 · Cited by 680
Rose-John, S., Scheller, J., Elson, G., & Jones, S. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105674 · Cited by 647 · cited 2×
“Alternatively, soluble IL17RC could function analogously to the IL-6 receptor (IL6R) system, in which a soluble IL-6Rα subunit promotes IL-6 binding to the gp130 receptor on cells that lack IL-6R, a process known as “trans-signaling” [45, 46].”
Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1439 · Cited by 614 · cited 7×
“It is currently unknown whether Act1, TRAF6, or other signaling intermediates bind directly to IL-17RC.”
InfluentialCarter, D. B., Deibel, M. R., Dunn, C. J., Tomich, C.-S. C., Laborde, A. L., Slightom, J. L., Berger, A. E., Bienkowski, M. J., Sun, F. F., McEwan, R. N., et al. (1990) · Nature · doi:10.1038/344633a0 · Cited by 601 · cited 1×
“If they exist, soluble IL-17RC molecules could act as decoy receptors to dampen signaling, analogous to the IL-1 receptor antagonist (IL1Ra) or receptor activator of NF-κB ligand (RANKL)/ osteoprotegerin systems [44].”
IL-17: prototype member of an emerging cytokine family
Aggarwal, S., & Gurney, A. L. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.1 · Cited by 597
Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H., & Maslinski, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2832 · Cited by 580
Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex
Toy, D., Kugler, D., Wolfson, M., Bos, T. V., Gurgel, J., Derry, J., Tocker, J., & Peschon, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.36 · Cited by 570 · cited 16×
“In contrast, hIL-17RC binds IL-17A and IL-17F with the same affinity [41].”
InfluentialInterleukin-17 is a negative regulator of established allergic asthma
Schnyder-Candrian, S., Togbe, D., Couillin, I., Mercier, I., Brombacher, F., Quesniaux, V., Fossiez, F., Ryffel, B., & Schnyder, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061401 · Cited by 564 · cited 1×
“In an ovalbumin–alum-induced asthma model, IL-17F restricts the pathogenic role of Th2 cells, whereas IL-17A and IL17RA promote Th2 responses in the lung [48, 91, 92].”
Hymowitz, S. G., Filvaroff, E. H., Yin, J., Lee, J., Cai, L., Risser, P., Maruoka, M., Mao, W., Foster, J., Kelley, R. F., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.19.5332 · Cited by 548 · cited 13×
“In contrast, hIL-17RC binds IL-17A and IL-17F with the same affinity [41].”
InfluentialThe roles of IL‐17A in inflammatory immune responses and host defense against pathogens
Iwakura, Y., Nakae, S., Saijo, S., & Ishigame, H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00699.x · Cited by 513 · cited 2×
“Conversely, IL-17RA is highly expressed in the bone marrow, thymus, and spleen, but relatively low levels are detected in colon, small intestine, and lung [26, 40, 42].”
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice
Ogawa, A., Andoh, A., Araki, Y., Bamba, T., & Fujiyama, Y. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.09.013 · Cited by 495 · cited 1×
“Furthermore, IL-17A also serves a protective function in a chemically induced model of colitis [49].”
Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S., & Iwakura, Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1035999100 · Cited by 490 · cited 1×
“Certain animal models that develop spontaneous arthritis including the IL-1Ra-deficient mice and SKG mice also require IL-17A expression for disease progression [70, 71].”
Hirota, K., Hashimoto, M., Yoshitomi, H., Tanaka, S., Nomura, T., Yamaguchi, T., Iwakura, Y., Sakaguchi, N., & Sakaguchi, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062259 · Cited by 482 · cited 1×
“Certain animal models that develop spontaneous arthritis including the IL-1Ra-deficient mice and SKG mice also require IL-17A expression for disease progression [70, 71].”
Khader, S. A., Gaffen, S. L., & Kolls, J. K. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.100 · Cited by 481 · cited 1×
“Th17 cells play a major role at mucosal surfaces to promote inflammation, providing a beneficial function in an infection setting and deleterious one in an autoimmune context [6, 7].”
Self-citationNumasaki, M., Watanabe, M., Suzuki, T., Takahashi, H., Nakamura, A., McAllister, F., Hishinuma, T., Goto, J., Lotze, M. T., Kolls, J. K., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6177 · Cited by 416 · cited 1×
“In humans, IL-17A-positive ovarian and lung cancer specimens displayed higher levels of angiogenesis compared to those devoid of IL-17A [54, 57].”
Kryczek, I., Wei, S., Zou, L., Altuwaijri, S., Szeliga, W., Kolls, J., Chang, A., & Zou, W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6730 · Cited by 416
IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1
Lee, J., Ho, W.-H., Maruoka, M., Corpuz, R. T., Baldwin, D. T., Foster, J. S., Goddard, A. D., Yansura, D. G., Vandlen, R. L., Wood, W. I., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008289200 · Cited by 405 · cited 1×
“IL-17E, more commonly called IL-25, shares structural features with other IL-17 family members, though its biologic functions differ considerably [11, 12].”
Endogenous IL-17 contributes to reduced tumor growth and metastasis
Kryczek, I., Wei, S., Szeliga, W., Vatan, L., & Zou, W. (2009) · Blood · doi:10.1182/blood-2008-09-177360 · Cited by 403 · cited 1×
“Growth enhancement of metastatic colon cancer cells in IL17A-deficient mice with an accompanied reduction in interferon (IFN)γ-producing natural killer and tumorspecific T cells supports a protective function for IL-17A [64].”
Yu, J. J., Ruddy, M. J., Wong, G. C., Sfintescu, C., Baker, P. J., Smith, J. B., Evans, R. T., & Gaffen, S. L. (2007) · Blood · doi:10.1182/blood-2005-09-010116 · Cited by 372 · cited 1×
“Counter to this, signaling via IL-17RA protects against periodontal bone loss in a mouse oral Porphyromonas gingivalis infection model, through a neutrophil recruitment mechanism [99].”
Self-citationLiang, S. C., Long, A. J., Bennett, F., Whitters, M. J., Karim, R., Collins, M., Goldman, S. J., Dunussi-Joannopoulos, K., Williams, C. M. M., Wright, J. F., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7791 · Cited by 371
Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308809200 · Cited by 364
Self-citationStructural basis for self-association and receptor recognition of human TRAF2
Park, Y. C., Burkitt, V., Villa, A. R., Tong, L., & Wu, H. (1999) · Nature · doi:10.1038/19110 · Cited by 358
Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor
Chang, S. H., Park, H., & Dong, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600256200 · Cited by 356 · cited 6×
“It is currently unknown whether Act1, TRAF6, or other signaling intermediates bind directly to IL-17RC.”
InfluentialIdentification of the IL-17 Receptor Related Molecule IL-17RC as the Receptor for IL-17F
Kuestner, R. E., Taft, D. W., Haran, A., Brandt, C. S., Brender, T., Lum, K., Harder, B., Okada, S., Ostrander, C. D., Kreindler, J. L., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5462 · Cited by 352 · cited 6×
“Therefore, in both humans and mice, IL-17RC appears to serve as a contact point for IL-17F (Table 1) [41].”
InfluentialCharacterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
Johansen, C., Usher, P. A., Kjellerup, R. B., Lundsgaard, D., Iversen, L., & Kragballe, K. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08902.x · Cited by 352 · cited 1×
“Surprisingly, gene transcript analyses of psoriatic lesions revealed an impairment of IL-17RC mRNA expression [80].”
Schwandner, R., Yamaguchi, K., & Cao, Z. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1233 · Cited by 349 · cited 1×
“The tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) adaptor serves as a molecular scaffold for a number of immune receptors, including the CD40 receptor (CD40R), the B cell-activating factor receptor (BAFFR), and IL-17RA [29, 30].”
Interleukin-17 inhibits tumor cell growth by means of a T-cell–dependent mechanism
Benchetrit, F., Ciree, A., Vives, V., Warnier, G., Gey, A., Sautès-Fridman, C., Fossiez, F., Haicheur, N., Fridman, W. H., & Tartour, E. (2002) · Blood · doi:10.1182/blood.v99.6.2114 · Cited by 347 · cited 1×
“Ectopic overexpression of IL-17A in hematopoietic tumor and sarcoma cells leads to enhanced antitumor immunity in immunocompetent mice [62, 63].”
Kirkham, B. W., Lassere, M. N., Edmonds, J. P., Juhasz, K. M., Bird, P. A., Lee, C. S., Shnier, R., & Portek, I. J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21749 · Cited by 336 · cited 1×
“Higher levels of synovial IL-17A are predictive of more severe joint damage in RA, supporting a causal role [75].”
Seiderer, J., Elben, I., Diegelmann, J., Glas, J., Stallhofer, J., Tillack, C., Pfennig, S., Jürgens, M., Schmechel, S., Konrad, A., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20339 · Cited by 329 · cited 1×
“Specific to the IBD spectrum, Crohn’s disease patients have significantly higher intestinal IL-17F levels than ulcerative colitis patients [83].”
Rickel, E. A., Siegel, L. A., Yoon, B.-R. P., Rottman, J. B., Kugler, D. G., Swart, D. A., Anders, P. M., Tocker, J. E., Comeau, M. R., & Budelsky, A. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4299 · Cited by 321 · cited 1×
“Indeed, IL-17RA oligomerizes with IL-17RB to form a receptor complex that interacts with IL-25/IL17E; accordingly, tissues sensitive to IL-25 may express higher levels of IL-17RA [43].”
Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells
Wright, J. F., Guo, Y., Quazi, A., Luxenberg, D. P., Bennett, F., Ross, J. F., Qiu, Y., Whitters, M. J., Tomkinson, K. N., Dunussi-Joannopoulos, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700499200 · Cited by 319 · cited 1×
“The IL-17A homodimer was found to be the most potent IL-17 family effector molecule based on its induction of the target gene CXCL1, followed by the IL17A/F heterodimer, and finally the IL-17F homodimer [15].”
Identification of Sef, a novel modulator of FGF signalling
Tsang, M., Friesel, R., Kudoh, T., & Dawid, I. B. (2002) · Nature Cell Biology · doi:10.1038/ncb749 · Cited by 304 · cited 1×
“IL-17RD is also known as similar expression to the fibroblast growth factor receptor (SEF), as it was initially described as having the same expression pattern as the fibroblast growth factor receptor during zebrafish development [19].”
The Structural Basis for the Recognition of Diverse Receptor Sequences by TRAF2
Ye, H., Park, Y. C., Kreishman, M., Kieff, E., & Wu, H. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80334-2 · Cited by 291
Tartour, É., Fossiez, F., Joyeux, I., Galinha, A., Gey, A., Claret, E. J., Sastre‐Garau, X., Couturier, J., Mosseri, V., Vives, V., et al. (1999) · PubMed · Cited by 290
IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?
Lubberts, E. (2008) · Cytokine · doi:10.1016/j.cyto.2007.09.014 · Cited by 289 · cited 1×
“Additionally, both IL-17A and IL-17F have been shown to promote the inflammatory pathology of a number of autoimmune diseases such as rheumatoid arthritis, lupus, psoriasis, and asthma (discussed in detail in subsequent sections) [17, 18].”
A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses
Chang, S. H., & Dong, C. (2007) · Cell Research · doi:10.1038/cr.2007.35 · Cited by 280
Huang, H., Kim, H. J., Chang, E.-J., Lee, Z. H., Hwang, S. J., Kim, H.-M., Lee, Y., & Kim, H.-H. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.74 · Cited by 272
Shen, F., Ruddy, M. J., Plamondon, P., & Gaffen, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904490 · Cited by 268 · cited 1×
“responses by driving the production of innate mediators such as IL-6, CXC chemokines, antimicrobial factors, and acute phase proteins [4, 5].”
Self-citationT-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17
Rangachari, M., Mauermann, N., Marty, R. R., Dirnhofer, S., Kurrer, M. O., Komnenovic, V., Penninger, J. M., & Eriksson, U. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052222 · Cited by 264 · cited 1×
“Moreover, neutralization of IL-17A leads to alleviation of disease in an experimental myocarditis model [86, 87].”
Kawaguchi, M., Takahashi, D., Hizawa, N., Suzuki, S., Matsukura, S., Kokubu, F., Maeda, Y., Fukui, Y., Konno, S., Huang, S.-K., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1346 · Cited by 257 · cited 1×
“In humans, a polymorphism in IL-17F leading to a missense mutation (His161Arg) is linked with protection against asthma development in a Japanese population [93].”
Shen, F., & Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.013 · Cited by 256
Self-citationJones, S. A., & Rose-John, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00319-1 · Cited by 255 · cited 2×
“Alternatively, soluble IL17RC could function analogously to the IL-6 receptor (IL6R) system, in which a soluble IL-6Rα subunit promotes IL-6 binding to the gp130 receptor on cells that lack IL-6R, a process known as “trans-signaling” [45, 46].”
The STIR-domain superfamily in signal transduction, development and immunity
Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubüser, A., & Eisenhaber, F. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00067-7 · Cited by 255 · cited 2×
“As noted above, IL-17R family members encode a novel, conserved signaling motif termed SEFIR that bears homology to the Toll/IL-1R (TIR) signaling domain on the Toll-like/IL-1 receptors [34].”
Bush, K. A., Farmer, K. M., Walker, J. S., & Kirkham, B. W. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10173 · Cited by 252
Nam, J.-S., Terabe, M., Kang, M.-J., Chae, H., Voong, N., Yang, Y.-A., Laurence, A., Michalowska, A., Mamura, M., Lonning, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0206 · Cited by 251
Cortez, D. M., Feldman, M. D., Mummidi, S., Valente, A. J., Steffensen, B., Vincenti, M., Barnes, J. L., & Chandrasekar, B. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00928.2007 · Cited by 241
IL-17 and Th17 cells in human inflammatory diseases
Miossec, P. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.003 · Cited by 236
An Anti-IL-12p40 Antibody Down-Regulates Type 1 Cytokines, Chemokines, and IL-12/IL-23 in Psoriasis
Toichi, E., Torres, G., McCormick, T. S., Chang, T., Mascelli, M. A., Kauffman, C. L., Aria, N., Gottlieb, A. B., Everitt, D. E., Frederick, B., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4917 · Cited by 229 · cited 2×
“Accordingly, clinical targeting of Th17 cells by antibodies that neutralize the IL-12/IL-23 p40 subunit results in a significant improvement in disease pathology in psoriatic patients, associated with a decrease in the mRNA of the p19 subunit of IL-23 [81, 82].”
Type 17 CD8+ T cells display enhanced antitumor immunity
Hinrichs, C. S., Kaiser, A., Paulos, C. M., Cassard, L., Sanchez-Perez, L., Heemskerk, B., Wrzesinski, C., Borman, Z. A., Muranski, P., & Restifo, N. P. (2009) · Blood · doi:10.1182/blood-2009-02-203935 · Cited by 225
Park, Y. C., Ye, H., Hsia, C., Segal, D., Rich, R. L., Liou, H.-C., Myszka, D. G., & Wu, H. (2000) · Cell · doi:10.1016/s0092-8674(00)80889-2 · Cited by 190
Interleukin-17: A novel inflammatory cytokine that bridges innate and adaptive immunity
Yu, J. (2008) · Frontiers in Bioscience · doi:10.2741/2667 · Cited by 178 · cited 1×
“The newly described interleukin (IL)-17 cytokine family, produced by a recently defined subset of CD4+ T helper (Th) cells known as “Th17”, has helped to bridge this gap, as Th17 cells connect the adaptive and innate immune responses [1].”
Neutralization of IL‐17 by active vaccination inhibits IL‐23‐dependent autoimmune myocarditis
Sonderegger, I., Röhn, T. A., Kurrer, M. O., Iezzi, G., Zou, Y., Kastelein, R. A., Bachmann, M. F., & Kopf, M. (2006) · European Journal of Immunology · doi:10.1002/eji.200636484 · Cited by 167 · cited 1×
“Moreover, neutralization of IL-17A leads to alleviation of disease in an experimental myocarditis model [86, 87].”
Maitra, A., Shen, F., Hanel, W., Mossman, K., Tocker, J., Swart, D., & Gaffen, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611589104 · Cited by 165 · cited 10×
“The N-terminus of Act1 contains a TRAFbinding domain while its C-terminus contains a SEF/IL-17R (SEFIR) domain, uniquely found on IL-17R family members [33].”
InfluentialSelf-citationExpression of IL-17 mRNA in Ovarian Cancer
Kato, T., Furumoto, H., Ogura, T., Onishi, Y., Irahara, M., Yamano, S., Kamada, M., & Aono, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4618 · Cited by 152 · cited 1×
“In humans, IL-17A-positive ovarian and lung cancer specimens displayed higher levels of angiogenesis compared to those devoid of IL-17A [54, 57].”
IL-17 and the Th17 lineage in systemic lupus erythematosus
Garrett-Sinha, L. A., John, S., & Gaffen, S. L. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328304b6b5 · Cited by 150 · cited 1×
“Additionally, both IL-17A and IL-17F have been shown to promote the inflammatory pathology of a number of autoimmune diseases such as rheumatoid arthritis, lupus, psoriasis, and asthma (discussed in detail in subsequent sections) [17, 18].”
Self-citationHwang, S.-Y., & Kim, H.-Y. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13153-0 · Cited by 145
Chapter 5 Emergence of the Th17 Pathway and Its Role in Host Defense
O’Quinn, D. B., Palmer, M. T., Lee, Y. K., & Weaver, C. T. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00605-6 · Cited by 141 · cited 2×
“The generation and function of IL-17-producing cells and the effects of their cognate cytokines have been reviewed extensively elsewhere [2, 3, 8, 9].”
Zrioual, S., Toh, M.-L., Tournadre, A., Zhou, Y., Cazalis, M.-A., Pachot, A., Miossec, V., & Miossec, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.655 · Cited by 137 · cited 1×
“Furthermore, based on RNAi blocking experiments, both IL-17RA and IL-17RC are required for the pro-inflammatory factors secreted by RA synoviocytes [76].”
Haudenschild, D., Moseley, T., Rose, L., & Reddi, A. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109372200 · Cited by 134 · cited 4×
“Variants labeled with asterisk have been independently verified [39, 41].”
InfluentialHirahara, N., Nio, Y., Sasaki, S., Minari, Y., Takamura, M., Iguchi, C., Dong, M., Yamasawa, K., & Tamura, K. (2001) · Oncology · doi:10.1159/000055357 · Cited by 123 · cited 1×
“Ectopic overexpression of IL-17A in hematopoietic tumor and sarcoma cells leads to enhanced antitumor immunity in immunocompetent mice [62, 63 ].”
Venkatachalam, K., Mummidi, S., Cortez, D. M., Prabhu, S. D., Valente, A. J., & Chandrasekar, B. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01363.2007 · Cited by 123 · cited 1×
“Furthermore, high glucose treatment of cardiac fibroblasts results in higher levels of IL-17A and IL-17RA expression but fails to modulate IL-17RC expression [89].”
Cutting Edge: Evidence for Ligand-Independent Multimerization of the IL-17 Receptor
Kramer, J. M., Yi, L., Shen, F., Maitra, A., Jiao, X., Jin, T., & Gaffen, S. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.711 · Cited by 116
Self-citationTargeting the development and effector functions of TH17 cells
Ghilardi, N., & Ouyang, W. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.016 · Cited by 106 · cited 2×
“The generation and function of IL-17-producing cells and the effects of their cognate cytokines have been reviewed extensively elsewhere [2, 3, 8, 9].”
IFNγ Promotes Papilloma Development by Up-regulating Th17-Associated Inflammation
Xiao, M., Wang, C., Zhang, J., Li, Z., Zhao, X., & Qin, Z. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3479 · Cited by 101
A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
Goswami, J., Hernández‐Santos, N., Zuniga, L. A., & Gaffen, S. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200939670 · Cited by 87 · cited 1×
“Recently, using a murine model of ovariectomyinduced osteoporosis, IL-17RA signaling was shown to protect from systemic bone loss due to estrogen deficiency [100].”
Self-citationAct1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling.
Li, X.-X. (2008) · Cytokine · doi:10.1016/j.cyto.2007.09.015 · Cited by 78 · cited 1×
“The N-terminus of Act1 contains a TRAFbinding domain while its C-terminus contains a SEF/IL-17R (SEFIR) domain, uniquely found on IL-17R family members [33].”
A new mechanism regulating the initiation of allergic airway inflammation
Kiss, A., Montes, M., Susarla, S. C., Gyllenbäck, E. J., Drouin, S. M., Wetsel, R. A., Yao, Z., Martin, R., Hamzeh, N. Y., Adelagun, R., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.025 · Cited by 69 · cited 1×
“Furthermore, neutrophil recruitment associated with allergen-induced airway inflammation by Aspergillus protease extract is reduced in IL-17F-deficient but not in IL-17A-deficient mice [90].”
Role of NFκB activator Act1 in CD40-mediated signaling in epithelial cells
Qian, Y., Zhao, Z., Jiang, Z., & Li, X. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142294499 · Cited by 66 · cited 1×
“The tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) adaptor serves as a molecular scaffold for a number of immune receptors, including the CD40 receptor (CD40R), the B cell-activating factor receptor (BAFFR), and IL-17RA [ 29 , 30].”
Kramer, J. M., Hanel, W., Shen, F., Isik, N., Malone, J. P., Maitra, A., Sigurdson, W., Swart, D., Tocker, J., Jin, T., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6379 · Cited by 59 · cited 1×
“Prior to the recognition that IL17RC was an integral part of the IL-17R complex, fluorescence resonance energy transfer (FRET) studies of IL-17RA indicated that IL-17RA multimers exist on the cell surface in the absence of ligand [23, 24].”
Self-citationSchwartz, S., Beaulieu, J., & Ruemmele, F. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.075 · Cited by 50 · cited 1×
“A report investigating the in vitro effects of IL-17A noted that it inhibits intestinal epithelial cell proliferation, an important mechanism of repair necessary to maintain epithelial integrity in a disease setting that destroys intestinal epithelium [84].”
Immunolocalization of IL-17A, IL-17B, and Their Receptors in Chondrocytes During Fracture Healing
Kokubu, T., Haudenschild, D. R., Moseley, T. A., Rose, L., & Reddi, A. H. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.7a7223.2007 · Cited by 48 · cited 1×
“Accordingly, IL-17A, IL-17RA, and IL17RC have been found to localize to the site of bone fracture and the epiphyseal growth plate [98].”
You, Z., Shi, X.-B., DuRaine, G., Haudenschild, D., Tepper, C. G., Hao Lo, S., Gandour-Edwards, R., de Vere White, R. W., & Reddi, A. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1130 · Cited by 41 · cited 3×
“The initial discovery of IL-17RCwas based on its high levels of expression in human prostate cancer cells [25, 39, 51].”
Role of Cytokines in Autoimmune Myocarditis and Cardiomyopathy
Furukawa, Y., Kobuke, K., & Matsumori, A. (2001) · Autoimmunity · doi:10.3109/08916930109007380 · Cited by 30 · cited 1×
“IL-17A correlates with autoimmune myocarditis, an inflammatory condition thought to result from immune targeting of cardiac myosin following myocardial infection [85].”
Haudenschild, D. R., Curtiss, S. B., Moseley, T. A., & Reddi, A. H. (2006) · The Prostate · doi:10.1002/pros.20422 · Cited by 24 · cited 1×
“The initial discovery of IL-17RCwas based on its high levels of expression in human prostate cancer cells [25, 39, 51].”
Cited by
The Role of IL-17 and related cytokines in inflammatory autoimmune diseases
Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/3908061 · Cited by 519
“Upon IL-17 stimulation, mRNA is dissociated and stabilized [29, 30].”
BackgroundBasic biology and role of interleukin‐17 in immunity and inflammation
Zenobia, C., & Hajishengallis, G. (2015) · Periodontology 2000 · doi:10.1111/prd.12083 · Cited by 470
“Interleukin-17RC is predominantly expressed in the epithelial cells of the prostate, kidney and joints, whereas interleukin-17RA is abundantly expressed in hematopoietic cell compartments (74).”
BackgroundTh17 Response and Inflammatory Autoimmune Diseases
Waite, J. C., & Skokos, D. (2012) · International Journal of Inflammation · doi:10.1155/2012/819467 · Cited by 238
“Act1 further interacts with TRAF6 and TAK1 to promote signal transduction and cytokine and chemokine secretion [25].”
BackgroundIL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Zepp, J., Wu, L., & Li, X. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.007 · Cited by 224
Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review
Boshtam, M., Asgary, S., Kouhpayeh, S., Shariati, L., & Khanahmad, H. (2017) · Inflammation · doi:10.1007/s10753-016-0477-1 · Cited by 215
Metadata
- Authors
- Ho, A. W., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- Seminars in Immunopathology
- Published
- 2009-12-13
- Volume
- 32
- Issue
- 1
- Pages
- 33-42
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- PMC
- PMC2837117
- OpenAlex
- W1993846314
- Cited by
- 104
- References
- 100
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 2 · 2023: 7 · 2022: 6 · 2021: 7 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 10 · 2016: 9 · 2015: 5 · 2014: 7 · 2013: 7 · 2012: 6
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Seminars in Immunopathology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR054389, R01AR054389)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17RC, IL-17 signaling, IL-17A, IL-17F, IL-17RA, signal transduction, inflammation, autoimmunity, host defense against infection
- MeSH terms
- Animals, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Signal Transduction, Autoimmunity, T-Lymphocyte Subsets, Interleukin-17, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.